PHASE II RANDOMIZED TRIAL OF OPTIMAL RECURRENCE-DIRECTED THERAPY (RDT) WITHOUT OR WITH ANDROGEN-DEPRIVATION THERAPY (ADT) IN RADIO-RECURRENT OLIGO-METASTATIC HORMONE/CASTRATE SENSITIVE PROSTATE CANCER (ROMCSPC): THE OCOG-RATIONAL-PCS TRIAL

被引：0

作者：

Gouveia, Andre ^{[1
]}

Vavassis, Peter ^{[2
]}

Mesci, Aruz ^{[3
]}

Hotte, Sebastien ^{[1
]}

Berlin, Alejandro ^{[3
]}

Zukotynski, Katherine ^{[1
]}

Morgan, Scott ^{[4
]}

Dayes, Ian ^{[1
]}

Perlis, Nathan ^{[5
]}

Wright, Jim ^{[1
]}

Pond, Gregory ^{[6
]}

Niazi, Tamim ^{[7
]}

Tsakiridis, Theodoros ^{[1
]}

机构：

[1] McMaster Univ, Hamilton, ON, Canada

[2] Hop Maison Neuve Rosemont, Montreal, PQ, Canada

[3] Princess Margaret Canc Ctr, Toronto, ON, Canada

[4] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada

[5] Univ Toronto, Toronto, ON, Canada

[6] Ontario Inst Canc Res, Hamilton, ON, Canada

[7] McGill Univ, Montreal, PQ, Canada

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

124

引用

页码：S54 / S55

页数：2